Year: 2013
Type: article
Abstract: rial commentary, 1 Viewpoint, 44 Reviews, 1 Systematic review, 121 Main papers, 10 Short reports, 1 Case report, 6 Commentaries, 8 Book reviews, 1 New Drug Mechanisms, 15 Letters to the Editors, 1 Obituary and 2 Proceedings/ Abstracts.There were two themed issues 'Agenda for Clinical Pharmacology' and 'Prescribing' .A key change in 2012 was the decision to remove the category of Short reports which in the past have attracted relatively few citations (some previously accepted papers in this category were published).Important papers do not have to be long to be accepted, but authors should select another category for them.The Editorial Board continued its focus on high quality invited reviews and this is illustrated in the statistics of the following paragraph.We received 646 submissions (15% higher compared with 2011), of which 398 (+11%) were original papers.Of the original articles, 17% have been accepted, with the remainder rejected, pending a decision or awaiting a revision.We have seen a more than 30% rise in submissions of reviews and meta-analyses, with 109 to date, as compared with 81 in 2011.Overall submissions for the period 31 October 2011 to 1 November 2012 came from 52 countries (49 countries in 2011 and 54 in 2010): United Kingdom (157, 21.0% of total), USA (99, 13.3%),China (61, 8.2%), the Netherlands (51, 6.9%), France (38, 5.1%), Australia (35, 4.7%), Germany (32, 4.3%), India (29, 3.9%), Italy (26, 3.5%), Japan (25, 3.4%), Switzerland (20, 2.7%), Spain (18, 2.4%), Denmark (13, 1.7%), Sweden (13, 1.7%), Korea (12, 1.6%), Canada (10, 1.3%) and 36 other countries (<10 submissions each).Papers were submitted and handled electronically via the ScholarOne website.Median times were as follows:
DOI: 10.1111/bcp.12046
Language: English
Subfield: History and Philosophy of Science
Field: Arts and Humanities
Domain: Social Sciences
Open Access status: bronze
OpenAlex ID: W1527590549